Targeting the aldo-keto reductase AKR1C3 in haemato-lymphoid malignancy
Project: Research
Participants
- Christopher Bunce (Principal Investigator)
- Mark Drayson (Co-Investigator)
Colleges, School and Institutes
| Short title | Targeting the aldo-keto reductase AKR1C3 in haemato-lymphoid malignancy |
|---|---|
| Status | Finished |
| Effective start/end date | 1/10/10 → 31/08/14 |